Efficacy Study of Anti-KIR Monoclonal Antibody as Maintenance Treatment in Acute Myeloid Leukemia (EFFIKIR)
Clinical trial NCT01687387 · COMPLETED
Trial details
- NCT number
- NCT01687387
- Sponsor
- Innate Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-11-17
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.